• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Transplant diagnostics Companies

    ID: MRFR/MED/0816-CR
    100 Pages
    Rahul Gotadki
    July 2018

    Transplant diagnostics companies play a critical role in the field of organ transplantation by providing diagnostic tests and solutions to ensure the compatibility and long-term success of organ and tissue transplants. These companies offer a range of products and services, including histocompatibility testing, organ matching, and monitoring for transplant recipients.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Transplant Diagnostics Market Research Report- Global Forecast Till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Transplant diagnostics Market

    Transplant Diagnostics Key Companies


    *Disclaimer: List of key companies in no particular order


    Latest Transplant diagnostics Companies Update



    • April 2023: Quest Diagnostics DGX announced the launch of Quest Advanced Specialized Transplant Services in April 2023. The portfolio includes over 170 specialized tests for transplants and infectious diseases, longitudinal trend analysis of test results in the physician's electronic medical record (EMR), and continual medical consultation to guarantee optimal test selection and findings interpretation that impact therapy. The early services that Quest Diagnostics provided in the field of transplant testing have been complemented by the company's full portfolio of advanced diagnostics and support services.



    • July 2023: Verici Dx, a firm that specializes in diagnostics based on RNA signatures and artificial intelligence technologies for kidney transplants, will begin selling its goods to the general public in July 2023. These not only enhance acceptance rates and expand the lifespan of organs, but they also make substantial strides in the improvement of treatment regimens and bring down the cost of medical care. The effectiveness of the platform has been demonstrated, and these two trials have the potential to pave the way for comparable scientific advances with regard to other subjects. To get started, you might want to take some Protega, which is a drug that was created to predict the risk of fibrosis and long-term graft failure.



    • October 2022: A reference laboratory was established by Plexision, a US-based biotechnology company, in Hyderabad, India, in October 2022. At this facility, patients waiting for transplants will have access to the complete range of diagnostic services that are available. Just a few examples include drug monitoring, pharmacogenomics, genetic testing, and the organization's very own diagnostics for determining the likelihood of rejection and viral infections in transplant patients. At the annual conference of the Indian Society for Organ Transplantation, which took place this week in Nagpur, India, the business presented its new products for the first time.


    List of Transplant diagnostics Key companies in the market

    • Becton Dickinson and Company (U.S.)

    • Bio-Rad Laboratories Inc (U.S.)

    • Illumina Inc (U.S.)

    • Immucor Transplant Diagnostics Inc (U.S.)

    • Thermo Fisher Scientific Inc (U.S.)

    • CareDx (U.S.)

    • Affymetrix Inc (U.S.)

    • Linkage Biosciences (U.S.)

    • Abbott Laboratories Inc (U.S.)

    • BioMérieux S.A. (France)

    • QIAGEN NV (Netherlands)